Other Species / Isoforms
  PRKD2 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K80-ub
ACSIVDQkFPECGFy
0 3
PRKD2 (human) ACSIVDQkFPECGFy K80-ub
PRKD2 iso3 (human) ACSIVDQKFPECGFY K80
PRKD2 (mouse) ACSIVDQKFPECGFY K80
PRKD2 (rat) ACSIVDQKFPECGFY K80
Y87-p
kFPECGFyGLYDkIL
Upstream
Downstream
1 0
Effects on Modified Protein
  • intracellular localization
Effects on Biological Processes:
  • cell adhesion, inhibited
  • cell motility, inhibited
Kinase, in vitro:
  • Src (human)
Putative in vivo kinases:
  • Src (human)
PRKD2 (human) kFPECGFyGLYDkIL Y87-p
PRKD2 iso3 (human) KFPECGFYGLYDKIL Y87
PRKD2 (mouse) KFPECGFYGLYDKIL Y87
PRKD2 (rat) KFPECGFYGLYDKIL Y87
K92-ub
GFyGLYDkILLFkHD
0 1
PRKD2 (human) GFyGLYDkILLFkHD K92-ub
PRKD2 iso3 (human) GFYGLYDKILLFKHD K92
PRKD2 (mouse) GFYGLYDKILLFKHD K92
PRKD2 (rat) GFYGLYDKILLFKHD K92
K97-ub
YDkILLFkHDPtSAN
0 1
PRKD2 (human) YDkILLFkHDPtSAN K97-ub
PRKD2 iso3 (human) YDKILLFKHDPTSAN K97
PRKD2 (mouse) YDKILLFKHDPTSAN K97
PRKD2 (rat) YDKILLFKHDPTSAN K97
T101-p
LLFkHDPtSANLLQL
0 1
PRKD2 (human) LLFkHDPtSANLLQL T101-p
PRKD2 iso3 (human) LLFKHDPTSANLLQL T101
PRKD2 (mouse) LLFKHDPTSANLLQL T101
PRKD2 (rat) LLFKHDPTSANLLQL T101
K178-ub
GCGLNYHkRCAFsIP
0 6
PRKD2 (human) GCGLNYHkRCAFsIP K178-ub
PRKD2 iso3 (human) GCGLNYHKRCAFSIP K178
PRKD2 (mouse) GCGLNYHKRCAFSIP K178
PRKD2 (rat) GCGLNYHKRCAFSIP K178
S183-p
YHkRCAFsIPNNCsG
0 1
PRKD2 (human) YHkRCAFsIPNNCsG S183-p
PRKD2 iso3 (human) YHKRCAFSIPNNCSG S183
PRKD2 (mouse) YHKRCAFSIPNNCSG S183
PRKD2 (rat) YHKRCAFSIPNNCSG S183
S189-p
FsIPNNCsGARKRRL
0 2
PRKD2 (human) FsIPNNCsGARKRRL S189-p
PRKD2 iso3 (human) FSIPNNCSGARKRRL S189
PRKD2 (mouse) FSIPNNCSGARKRRL S189
PRKD2 (rat) FSIPNNCSGARKRRL S189
S197-p
GARKRRLsstsLAsG
Upstream
0 358
Treatment
  • AZD1152
  • EGF
  • gefitinib
  • LPA
  • Su11274
  • U0126
  • ZM447439
PRKD2 (human) GARKRRLsstsLAsG S197-p
PRKD2 iso3 (human) GARKRRLSSTSLASG S197
PRKD2 (mouse) GARKRRLsstsLAsG S197-p
PRKD2 (rat) GARKRRLsSTSLAsG S197-p
S198-p
ARKRRLsstsLAsGH
Upstream
1 202
Treatment
  • gefitinib
  • LPA
  • Su11274
  • U0126
PRKD2 (human) ARKRRLsstsLAsGH S198-p
PRKD2 iso3 (human) ARKRRLSSTSLASGH S198
PRKD2 (mouse) ARKRRLsstsLAsGH S198-p
PRKD2 (rat) ARKRRLsSTSLAsGH S198
T199-p
RKRRLsstsLAsGHs
0 45
PRKD2 (human) RKRRLsstsLAsGHs T199-p
PRKD2 iso3 (human) RKRRLSSTSLASGHS T199
PRKD2 (mouse) RKRRLsstsLAsGHs T199-p
PRKD2 (rat) RKRRLsSTSLAsGHS T199
S200-p
KRRLsstsLAsGHsV
Upstream
0 67
Treatment
  • LPA
  • SII_angiotensin_2
  • U0126
PRKD2 (human) KRRLsstsLAsGHsV S200-p
PRKD2 iso3 (human) KRRLSSTSLASGHSV S200
PRKD2 (mouse) KRRLsstsLAsGHsV S200-p
PRKD2 (rat) KRRLsSTSLAsGHSV S200
S203-p
LsstsLAsGHsVRLG
Upstream
0 46
Regulatory protein:
  • PRKD1 (human)
Treatment
  • angiotensin_2
  • SII_angiotensin_2
PRKD2 (human) LsstsLAsGHsVRLG S203-p
PRKD2 iso3 (human) LSSTSLASGHSVRLG S203
PRKD2 (mouse) LsstsLAsGHsVRLG S203-p
PRKD2 (rat) LsSTSLAsGHSVRLG S203-p
S206-p
tsLAsGHsVRLGtsE
Upstream
0 41
Treatment
  • LPA
  • LRRK2-IN-1
  • MLN8054
PRKD2 (human) tsLAsGHsVRLGtsE S206-p
PRKD2 iso3 (human) TSLASGHSVRLGTSE S206
PRKD2 (mouse) tsLAsGHsVRLGssE S206-p
PRKD2 (rat) TSLAsGHSVRLGsSE S206
T211-p
GHsVRLGtsEsLPCT
0 30
PRKD2 (human) GHsVRLGtsEsLPCT T211-p
PRKD2 iso3 (human) GHSVRLGTSESLPCT T211
PRKD2 (mouse) GHsVRLGssEsLPCT S211-p
PRKD2 (rat) GHSVRLGsSEsLPCT S211-p
S212-p
HsVRLGtsEsLPCTA
0 5
PRKD2 (human) HsVRLGtsEsLPCTA S212-p
PRKD2 iso3 (human) HSVRLGTSESLPCTA S212
PRKD2 (mouse) HsVRLGssEsLPCTA S212-p
PRKD2 (rat) HSVRLGsSEsLPCTA S212
S214-p
VRLGtsEsLPCTAEE
Upstream
0 97
Treatment
  • anti-CD3
  • ischemia
PRKD2 (human) VRLGtsEsLPCTAEE S214-p
PRKD2 iso3 (human) VRLGTSESLPCTAEE S214
PRKD2 (mouse) VRLGssEsLPCTAEE S214-p
PRKD2 (rat) VRLGsSEsLPCTAEE S214-p
S225-p
TAEELSRsTtELLPR
0 2
PRKD2 (human) TAEELSRsTtELLPR S225-p
PRKD2 iso3 (human) TAEELSRSTTELLPR S225
PRKD2 (mouse) TAEELSRSTTDLLPR S225
PRKD2 (rat) TAEELSRSTTDLLPR S225
T227-p
EELSRsTtELLPRRP
0 3
PRKD2 (human) EELSRsTtELLPRRP T227-p
PRKD2 iso3 (human) EELSRSTTELLPRRP T227
PRKD2 (mouse) EELSRSTTDLLPRRP T227
PRKD2 (rat) EELSRSTTDLLPRRP T227
S236-p
LLPRRPPssssSssA
0 9
PRKD2 (human) LLPRRPPssssSssA S236-p
PRKD2 iso3 (human) LLPRRPPSSSSSSSA S236
PRKD2 (mouse) LLPRRPPSSSSSSSS S236
PRKD2 (rat) LLPRRPPSSSSSSSS S236
S237-p
LPRRPPssssSssAs
0 2
PRKD2 (human) LPRRPPssssSssAs S237-p
PRKD2 iso3 (human) LPRRPPSSSSSSSAS S237
PRKD2 (mouse) LPRRPPSSSSSSSSS S237
PRKD2 (rat) LPRRPPSSSSSSSSS S237
S238-p
PRRPPssssSssAss
0 3
PRKD2 (human) PRRPPssssSssAss S238-p
PRKD2 iso3 (human) PRRPPSSSSSSSASS S238
PRKD2 (mouse) PRRPPSSSSSSSSSS S238
PRKD2 (rat) PRRPPSSSSSSSSSS S238
S239-p
RRPPssssSssAssy
0 1
PRKD2 (human) RRPPssssSssAssy S239-p
PRKD2 iso3 (human) RRPPSSSSSSSASSY S239
PRKD2 (mouse) RRPPSSSSSSSSSSF S239
PRKD2 (rat) RRPPSSSSSSSSSSF S239
S241-p
PPssssSssAssyTG
0 4
PRKD2 (human) PPssssSssAssyTG S241-p
PRKD2 iso3 (human) PPSSSSSSSASSYTG S241
PRKD2 (mouse) PPSSSSSSSSSSFYT S241
PRKD2 (rat) PPSSSSSSSSSSFYT S241
S242-p
PssssSssAssyTGR
0 5
PRKD2 (human) PssssSssAssyTGR S242-p
PRKD2 iso3 (human) PSSSSSSSASSYTGR S242
PRKD2 (mouse) PSSSSSSSSSSFYTG S242
PRKD2 (rat) PSSSSSSSSSSFYTG S242
S244-p
sssSssAssyTGRPI
Upstream
Downstream
1 2
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
Effects on Biological Processes:
  • transcription, induced
Kinase, in vitro:
  • CK1D (human)
  • CK1E (human)
Putative in vivo kinases:
  • CK1D (human)
  • CK1E (human)
Treatment
  • CKI-7
  • D4476
  • gastrin
  • IC261
  • siRNA
PRKD2 (human) sssSssAssyTGRPI S244-p
PRKD2 iso3 (human) SSSSSSASSYTGRPI S244
PRKD2 (mouse) SSSSSSSSSFYTGRP S244
PRKD2 (rat) SSSSSSSSSFYTGRP S244
S245-p
ssSssAssyTGRPIE
0 2
PRKD2 (human) ssSssAssyTGRPIE S245-p
PRKD2 iso3 (human) SSSSSASSYTGRPIE S245
PRKD2 (mouse) SSSSSSSSFYTGRPI S245
PRKD2 (rat) SSSSSSSSFYTGRPI S245
Y246-p
sSssAssyTGRPIEL
0 4
PRKD2 (human) sSssAssyTGRPIEL Y246-p
PRKD2 iso3 (human) SSSSASSYTGRPIEL Y246
PRKD2 (mouse) SSSSSSFYTGRPIEL Y247
PRKD2 (rat) SSSSSSFYTGRPIEL Y247
K255-ub
GRPIELDkMLLSKVK
0 1
PRKD2 (human) GRPIELDkMLLSKVK K255-ub
PRKD2 iso3 (human) GRPIELDKMLLSKVK K255
PRKD2 (mouse) GRPIELDKMLMSKVK K256
PRKD2 (rat) GRPIELDKMLMSKVK K256
Y272-p
HTFLIHSyTRPTVCQ
0 1
PRKD2 (human) HTFLIHSyTRPTVCQ Y272-p
PRKD2 iso3 (human) HTFLIHSYTRPTVCQ Y272
PRKD2 (mouse) HTFLIHSYTRPTVCQ Y273
PRKD2 (rat) HTFLIHSYTRPTVCQ Y273
K286-ub
QACKKLLkGLFRQGL
0 2
PRKD2 (human) QACKKLLkGLFRQGL K286-ub
PRKD2 iso3 (human) QACKKLLKGLFRQGL K286
PRKD2 (mouse) QACKKLLkGLFRQGL K287-ub
PRKD2 (rat) QACKKLLKGLFRQGL K287
S355-p
GVIPGSHsENALHAs
0 1
PRKD2 (human) GVIPGSHsENALHAs S355-p
PRKD2 iso3 (human) GVIPGSHSENALHAS S355
PRKD2 (mouse) GVIPGSHSESALHAS S356
PRKD2 (rat) GVIPGSHAENALHAS A356
S362-p
sENALHAsEEEEGEG
0 2
PRKD2 (human) sENALHAsEEEEGEG S362-p
PRKD2 iso3 (human) SENALHASEEEEGEG S362
PRKD2 (mouse) SESALHASEEEEGEG S363
PRKD2 (rat) AENALHASEEEEGEG S363
S374-p
GEGGKAQssLGyIPL
0 3
PRKD2 (human) GEGGKAQssLGyIPL S374-p
PRKD2 iso3 (human) GEGGKAQSSLGYIPL S374
PRKD2 (mouse) GEGHKAQssLGYIPL S375-p
PRKD2 (rat) GEGGKAQSSLGYIPL S375
S375-p
EGGKAQssLGyIPLM
0 15
PRKD2 (human) EGGKAQssLGyIPLM S375-p
PRKD2 iso3 (human) EGGKAQSSLGYIPLM S375
PRKD2 (mouse) EGHKAQssLGYIPLM S376-p
PRKD2 (rat) EGGKAQSSLGYIPLM S376
Y378-p
KAQssLGyIPLMRVV
0 17
PRKD2 (human) KAQssLGyIPLMRVV Y378-p
PRKD2 iso3 (human) KAQSSLGYIPLMRVV Y378
PRKD2 (mouse) KAQssLGYIPLMRVV Y379
PRKD2 (rat) KAQSSLGYIPLMRVV Y379
S387-p
PLMRVVQsVRHttRK
0 9
PRKD2 (human) PLMRVVQsVRHttRK S387-p
PRKD2 iso3 (human) PLMRVVQSVRHTTRK S387
PRKD2 (mouse) PLMRVVQsVRHTTRK S388-p
PRKD2 (rat) PLMRVVQSVRHTTRK S388
T391-p
VVQsVRHttRKssTt
0 8
PRKD2 (human) VVQsVRHttRKssTt T391-p
PRKD2 iso3 (human) VVQSVRHTTRKSSTT T391
PRKD2 (mouse) VVQsVRHTTRKSsTt T392
PRKD2 (rat) VVQSVRHTTRKSSTT T392
T392-p
VQsVRHttRKssTtL
0 5
PRKD2 (human) VQsVRHttRKssTtL T392-p
PRKD2 iso3 (human) VQSVRHTTRKSSTTL T392
PRKD2 (mouse) VQsVRHTTRKSsTtL T393
PRKD2 (rat) VQSVRHTTRKSSTTL T393
S395-p
VRHttRKssTtLREG
0 12
PRKD2 (human) VRHttRKssTtLREG S395-p
PRKD2 iso3 (human) VRHTTRKSSTTLREG S395
PRKD2 (mouse) VRHTTRKSsTtLREG S396
PRKD2 (rat) VRHTTRKSSTTLREG S396
S396-p
RHttRKssTtLREGW
Upstream
0 51
Treatment
  • angiotensin_2
PRKD2 (human) RHttRKssTtLREGW S396-p
PRKD2 iso3 (human) RHTTRKSSTTLREGW S396
PRKD2 (mouse) RHTTRKSsTtLREGW S397-p
PRKD2 (rat) RHTTRKSSTTLREGW S397
T398-p
ttRKssTtLREGWVV
0 3
PRKD2 (human) ttRKssTtLREGWVV T398-p
PRKD2 iso3 (human) TTRKSSTTLREGWVV T398
PRKD2 (mouse) TTRKSsTtLREGWVV T399-p
PRKD2 (rat) TTRKSSTTLREGWVV T399
T412-p
VHYSNKDtLRKRHYW
0 7
PRKD2 (human) VHYSNKDtLRKRHYW T412-p
PRKD2 iso3 (human) VHYSNKDTLRKRHYW T412
PRKD2 (mouse) VHYSNKDTLRKRHYW T413
PRKD2 (rat) VHYSNKDTLRKRHYW T413
K424-ub
HYWRLDCkCITLFQN
0 3
PRKD2 (human) HYWRLDCkCITLFQN K424-ub
PRKD2 iso3 (human) HYWRLDCKCITLFQN K424
PRKD2 (mouse) HYWRLDCKCITLFQN K425
PRKD2 (rat) HYWRLDCKCITLFQN K425
Y438-p
NNTTNRYyKEIPLSE
0 1
PRKD2 (human) NNTTNRYyKEIPLSE Y438-p
PRKD2 iso3 (human) NNTTNRYYKEIPLSE Y438
PRKD2 (mouse) NNTTNRYYKEIPLSE Y439
PRKD2 (rat) NNTTNRYYKEIPLSE Y439
S518-p
VILQDAPsAPGHAPH
Upstream
0 15
Treatment
  • LPA
PRKD2 (human) VILQDAPsAPGHAPH S518-p
PRKD2 iso3 (human) VILQDAPSAPGHAPH S518
PRKD2 (mouse) VILQDAPSAPGHTPH S519
PRKD2 (rat) VILQDAPSAPGHTPH S519
S529-p
HAPHRQAsLSISVSN
0 1
PRKD2 (human) HAPHRQAsLSISVSN S529-p
PRKD2 iso3 (human) HAPHRQASLSISVSN S529
PRKD2 (mouse) HTPHRQASLSISVSN S530
PRKD2 (rat) HTPHRQASLSISVSN S530
K572-ac
VYGGKHRkTGRDVAV
0 1
PRKD2 (human) VYGGKHRkTGRDVAV K572-ac
PRKD2 iso3 (human) VYGGKHRKTGRDVAV K572
PRKD2 (mouse) VYGGKHRKTGRDVAV K573
PRKD2 (rat) VYGGKHRKTGRDVAV K573
K580-ac
TGRDVAVkVIDkLRF
0 1
PRKD2 (human) TGRDVAVkVIDkLRF K580-ac
PRKD2 iso3 (human) TGRDVAVKVIDKLRF K580
PRKD2 (mouse) TGRDVAVKVIDKLRF K581
PRKD2 (rat) TGRDVAVKVIDKLRF K581
K580-ub
TGRDVAVkVIDkLRF
0 2
PRKD2 (human) TGRDVAVkVIDkLRF K580-ub
PRKD2 iso3 (human) TGRDVAVKVIDKLRF K580
PRKD2 (mouse) TGRDVAVKVIDKLRF K581
PRKD2 (rat) TGRDVAVKVIDKLRF K581
K584-ac
VAVkVIDkLRFPTKQ
0 1
PRKD2 (human) VAVkVIDkLRFPTKQ K584-ac
PRKD2 iso3 (human) VAVKVIDKLRFPTKQ K584
PRKD2 (mouse) VAVKVIDKLRFPTKQ K585
PRKD2 (rat) VAVKVIDKLRFPTKQ K585
T619-p
NLECMFEtPEKVFVV
0 1
PRKD2 (human) NLECMFEtPEKVFVV T619-p
PRKD2 iso3 (human) NLECMFETPEKVFVV T619
PRKD2 (mouse) NLECMFETPEKVFVV T620
PRKD2 (rat) NLECMFETPEKVFVV T620
K705-ub
FARIIGEksFRRsVV
0 2
PRKD2 (human) FARIIGEksFRRsVV K705-ub
PRKD2 iso3 (human) FARIIGEKSFRRSVV K705
PRKD2 (mouse) FARIIGEksFRRsVV K706-ub
PRKD2 (rat) FARIIGEKSFRRsVV K706
S706-p
ARIIGEksFRRsVVG
Upstream
Downstream
5 31
Effects on Modified Protein
  • enzymatic activity, induced
  • molecular association, regulation
Effects on Biological Processes:
  • transcription, induced
Putative in vivo kinases:
  • PKCA (human)
  • PKCE (human)
  • PKCH (human)
Regulatory protein:
  • CK1D (human)
  • CK1E (human)
Treatment
  • CKI-7
  • D4476
  • ET18OCH3
  • gastrin
  • HB-EGF
  • IC261
  • LPA
  • phorbol_ester
PRKD2 (human) ARIIGEksFRRsVVG S706-p
PRKD2 iso3 (human) ARIIGEKSFRRSVVG S706
PRKD2 (mouse) ARIIGEksFRRsVVG S707-p
PRKD2 (rat) ARIIGEKSFRRsVVG S707
S710-p
GEksFRRsVVGtPAy
Upstream
Downstream
5 88
Effects on Modified Protein
  • enzymatic activity, induced
  • molecular association, regulation
Effects on Biological Processes:
  • transcription, induced
Putative in vivo kinases:
  • PKCA (human)
  • PKCE (human)
  • PKCH (human)
Regulatory protein:
  • CK1D (human)
  • CK1E (human)
  • PRKD1 (human)
  • TBK1 (human)
Treatment
  • anti-CD3
  • CKI-7
  • D4476
  • ET18OCH3
  • gastrin
  • HB-EGF
  • IC261
  • ischemia
  • LPA
  • phorbol_ester
PRKD2 (human) GEksFRRsVVGtPAy S710-p
PRKD2 iso3 (human) GEKSFRRSVVGTPAY S710
PRKD2 (mouse) GEksFRRsVVGTPAY S711-p
PRKD2 (rat) GEKSFRRsVVGTPAY S711-p
T714-p
FRRsVVGtPAyLAPE
0 17
PRKD2 (human) FRRsVVGtPAyLAPE T714-p
PRKD2 iso3 (human) FRRSVVGTPAYLAPE T714
PRKD2 (mouse) FRRsVVGTPAYLAPE T715
PRKD2 (rat) FRRsVVGTPAYLAPE T715
Y717-p
sVVGtPAyLAPEVLL
0 45
PRKD2 (human) sVVGtPAyLAPEVLL Y717-p
PRKD2 iso3 (human) SVVGTPAYLAPEVLL Y717
PRKD2 (mouse) sVVGTPAYLAPEVLL Y718
PRKD2 (rat) sVVGTPAYLAPEVLL Y718
S876-p
QGLAERIsVL_____
Upstream
Downstream
5 10
Effects on Modified Protein
  • enzymatic activity, induced
Kinase, in vitro:
  • PRKD2 (human)
Putative in vivo kinases:
  • PKCA (human)
  • PKCE (human)
  • PKCH (human)
Treatment
  • ET18OCH3
  • gastrin
  • GF109203X
  • LPA
  • phorbol_ester
  • Ro31-8220
PRKD2 (human) QGLAERIsVL_____ S876-p
PRKD2 iso3 (human) QGLAERISVL_____ S886
PRKD2 (mouse) QGLAERIsIL_____ S873-p
PRKD2 (rat) QGLAERISIL_____ S873